{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:00Z","timestamp":1787026500739,"version":"build-2736575974"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The role for human herpesvirus (HHV)-6A or HHV-6B in multiple sclerosis (MS) pathogenesis has been controversial. Possibly because the damage of the virus infection may occur before onset of clinical symptoms and because it has been difficult to detect active infection and separate serological responses to HHV-6A or 6B. Recent studies report that in MS patients the serological response against HHV-6A is increased whereas it is decreased against HHV-6B. This effect seems to be even more pronounced in MS patients prior to diagnosis and supports previous studies postulating a predomination for HHV-6A in MS disease and suggests that the infection is important at early stages of the disease. Furthermore, HHV-6A infection interacts with other factors suspected of modulating MS susceptibility and progression such as infection with Epstein-Barr virus (EBV) and Cytomegalovirus (CMV), tobacco smoking, HLA alleles, UV irradiation and vitamin D levels. The multifactorial nature of MS and pathophysiological role for HHV-6A in inflammation and autoimmunity are discussed.<\/jats:p>","DOI":"10.3389\/fimmu.2022.840753","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T01:02:11Z","timestamp":1644454931000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Wangko","family":"Lundstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple Sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811405097","article-title":"Studies Based on the Danish Multiple Sclerosis Registry","volume":"39","author":"Koch-Henriksen","year":"2011","journal-title":"Scand J Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198612253152603","article-title":"A Population-Based Study of Multiple Sclerosis in Twins","volume":"315","author":"Ebers","year":"1986","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature10251","article-title":"Genetic Risk and a Primary Role for Cell-Mediated Immune Mechanisms in Multiple Sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions Between Genetic, Lifestyle and Environmental Risk Factors for Multiple Sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2011.240432","article-title":"Latitude Is Significantly Associated With the Prevalence of Multiple Sclerosis: A Meta-Analysis","volume":"82","author":"Simpson","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10405","article-title":"Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti-Inflammatory","author":"Bishop","year":"2020","journal-title":"JBMR Plus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq371","article-title":"Smoking and Two Human Leukocyte Antigen Genes Interact to Increase the Risk for Multiple Sclerosis","volume":"134","author":"Hedstrom","year":"2011","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.757302","article-title":"Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis","volume":"12","author":"Meier","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.2876520","article-title":"Isolation of a New Virus, HBLV, in Patients With Lymphoproliferative Disorders","volume":"234","author":"Salahuddin","year":"1986","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-013-1902-5","article-title":"Classification of HHV-6A and HHV-6B as Distinct Viruses","volume":"159","author":"Ablashi","year":"2014","journal-title":"Arch Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50960","article-title":"Comprehensive Annotations of Human Herpesvirus 6A and 6B Genomes Reveal Novel and Conserved Genomic Features","volume":"9","author":"Finkel","year":"2020","journal-title":"Elife"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81678-5","article-title":"CD46 Is a Cellular Receptor for Human Herpesvirus 6","volume":"99","author":"Santoro","year":"1999","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1305187110","article-title":"CD134 Is a Cellular Receptor Specific for Human Herpesvirus-6B Entry","volume":"110","author":"Tang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.27.4.651-653.1989","article-title":"Seroepidemiology of Human Herpesvirus 6 Infection in Normal Children and Adults","volume":"27","author":"Okuno","year":"1989","journal-title":"J Clin Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042207","article-title":"A Population-Based Study of Primary Human Herpesvirus 6 Infection","volume":"352","author":"Zerr","year":"2005","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21455","article-title":"Predominant Human Herpesvirus 6 Variant A Infant Infections in an HIV-1 Endemic Region of Sub-Saharan Africa","volume":"81","author":"Bates","year":"2009","journal-title":"J Med Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1086\/503434","article-title":"Characteristics and Acquisition of Human Herpesvirus (HHV) 7 Infections in Relation to Infection With HHV-6","volume":"193","author":"Hall","year":"2006","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<88::AID-JMV14>3.0.CO;2-2","article-title":"Seroepidemiological Study of Human Herpesvirus-6 and -7 in Children of Different Ages and Detection of These Two Viruses in Throat Swabs by Polymerase Chain Reaction","volume":"48","author":"Tanaka-Taya","year":"1996","journal-title":"J Med Virol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.062216","article-title":"Human Herpesviruses-6 and -7 Each Cause Significant Neurological Morbidity in Britain and Ireland","volume":"90","author":"Ward","year":"2005","journal-title":"Arch Dis Child"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(88)91893-4","article-title":"Identification of Human Herpesvirus-6 as a Causal Agent for Exanthem Subitum","volume":"1","author":"Yamanishi","year":"1988","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A","article-title":"Increased Lymphoproliferative Response to Human Herpesvirus Type 6A Variant in Multiple Sclerosis Patients","volume":"47","author":"Soldan","year":"2000","journal-title":"Ann Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02715","article-title":"Increased Serological Response Against Human Herpesvirus 6a Is Associated With Risk for Multiple Sclerosis","volume":"10","author":"Engdahl","year":"2019","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12967-018-1450-6","article-title":"HLA Alleles Modulate EBV Viral Load in Multiple Sclerosis","volume":"16","author":"Agostini","year":"2018","journal-title":"J Transl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr Virus Infection in the Multiple Sclerosis Brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020100","article-title":"The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases","volume":"347","author":"Bach","year":"2002","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515595876","article-title":"Viral Exposures and MS Outcome in a Prospective Cohort of Children With Acquired Demyelination","volume":"22","author":"Makhani","year":"2016","journal-title":"Mult Scler"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318224947f","article-title":"Molecular Diagnostic Tests for Human Herpesvirus 6","volume":"30","author":"Kainth","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2010.02.007","article-title":"Diagnostic Assays for Active Infection With Human Herpesvirus 6 (HHV-6)","volume":"48","author":"Caserta","year":"2010","journal-title":"J Clin Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.12.019","article-title":"Human Herpesvirus-6 (HHV-6) DNA in Plasma Reflects the Presence of Infected Blood Cells Rather Than Circulating Viral Particles","volume":"38","author":"Achour","year":"2007","journal-title":"J Clin Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21839","article-title":"Review, Part 1: Human Herpesvirus-6-Basic Biology, Diagnostic Testing, and Antiviral Efficacy","volume":"82","author":"Flamand","year":"2010","journal-title":"J Med Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/13550280290049615-1","article-title":"Increased Detection of Serum HHV-6 DNA Sequences During Multiple Sclerosis (MS) Exacerbations and Correlation With Parameters of MS Disease Progression","volume":"8","author":"Berti","year":"2002","journal-title":"J Neurovirol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.18.11914-11924.2005","article-title":"The Human Herpesvirus 6 G Protein-Coupled Receptor Homolog U51 Positively Regulates Virus Replication and Enhances Cell-Cell Fusion In Vitro","volume":"79","author":"Zhen","year":"2005","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.virol.2008.11.049","article-title":"Role of Dendritic Cells Infected With Human Herpesvirus 6 in Virus Transmission to CD4(+) T Cells","volume":"385","author":"Takemoto","year":"2009","journal-title":"Virology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10388","article-title":"Evaluation of Active Human Herpesvirus 6 Infection by Reverse Transcription-PCR","volume":"70","author":"Yoshikawa","year":"2003","journal-title":"J Med Virol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e92328","DOI":"10.1371\/journal.pone.0092328","article-title":"Coinfection of Human Herpesviruses 6A (HHV-6A) and HHV-6B as Demonstrated by Novel Digital Droplet PCR Assay","volume":"9","author":"Leibovitch","year":"2014","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e104836","DOI":"10.1371\/journal.pone.0104836","article-title":"Anti-Human Herpesvirus 6A\/B IgG Correlates With Relapses and Progression in Multiple Sclerosis","volume":"9","author":"Ortega-Madueno","year":"2014","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1348-0421.1992.tb02047.x","article-title":"IgM Neutralizing Antibody Responses to Human Herpesvirus-6 in Patients With Exanthem Subitum or Organ Transplantation","volume":"36","author":"Suga","year":"1992","journal-title":"Microbiol Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-008-0021-6","article-title":"Prevalence of Human Herpesvirus 6 Antibodies and DNA in Allogeneic Stem Cell Transplant Patients: Two-Year Single Centre Experience","volume":"56","author":"Dzieciatkowski","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199408183310703","article-title":"Human Herpesvirus-6 Infection in Children. A Prospective Study of Complications and Reactivation","volume":"331","author":"Hall","year":"1994","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1086\/317624","article-title":"Reactivation and Shedding of Cytomegalovirus in Astronauts During Spaceflight","volume":"182","author":"Mehta","year":"2000","journal-title":"J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1086\/368172","article-title":"Human Herpesvirus 6 Genome and Antigen in Acute Multiple Sclerosis Lesions","volume":"187","author":"Goodman","year":"2003","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh390","article-title":"Early and Late HHV-6 Gene Transcripts in Multiple Sclerosis Lesions and Normal Appearing White Matter","volume":"128","author":"Opsahl","year":"2005","journal-title":"Brain"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.16.7440","article-title":"Plaque-Associated Expression of Human Herpesvirus 6 in Multiple Sclerosis","volume":"92","author":"Challoner","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/135245859900500509","article-title":"The Association of the Human Herpesvirus-6 and MS","volume":"5","author":"Friedman","year":"1999","journal-title":"Mult Scler"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0794-z","article-title":"Intrathecal Antibody (IgG) Production Against Human Herpesvirus Type 6 Occurs in About 20% of Multiple Sclerosis Patients and Might be Linked to a Polyspecific B-Cell Response","volume":"252","author":"Derfuss","year":"2005","journal-title":"J Neurol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/13550280701381332","article-title":"Evidence for Human Herpesvirus 6 Variant A Antibodies in Multiple Sclerosis: Diagnostic and Therapeutic Implications","volume":"13","author":"Virtanen","year":"2007","journal-title":"J Neurovirol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/135245859800400606","article-title":"Human Herpesvirus-6 (HHV-6) Infection in Multiple Sclerosis: A Preliminary Report","volume":"4","author":"Ablashi","year":"1998","journal-title":"Mult Scler"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.06.012","article-title":"Intrathecal Human Herpesvirus 6 Antibodies in Multiple Sclerosis and Other Demyelinating Diseases Presenting as Oligoclonal Bands in Cerebrospinal Fluid","volume":"237","author":"Virtanen","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1352458513490545","article-title":"Oligoclonal Bands in Multiple Sclerosis Reactive Against Two Herpesviruses and Association With Magnetic Resonance Imaging Findings","volume":"20","author":"Virtanen","year":"2014","journal-title":"Mult Scler"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10258","article-title":"Correlation Between HHV-6 Reactivation and Multiple Sclerosis Disease Activity","volume":"69","author":"Chapenko","year":"2003","journal-title":"J Med Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0350","article-title":"Human Herpesvirus 6 Infection as a Trigger of Multiple Sclerosis","volume":"85","author":"Voumvourakis","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1034\/j.1600-0404.2002.01251.x","article-title":"Human Herpes Virus 6 and Multiple Sclerosis","volume":"106","author":"Moore","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.10.1523","article-title":"Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection","volume":"61","author":"Alvarez-Lafuente","year":"2004","journal-title":"Arch Neurol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(06)70007-5","article-title":"Clinical Parameters and HHV-6 Active Replication in Relapsing-Remitting Multiple Sclerosis Patients","author":"Alvarez-Lafuente","year":"2006","journal-title":"J Clin Virol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/1352458511428081","article-title":"Anti-HHV-6 IgG Titer Significantly Predicts Subsequent Relapse Risk in Multiple Sclerosis","volume":"18","author":"Simpson","year":"2012","journal-title":"Mult Scler"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104740","article-title":"Human Herpesvirus 6 and Central Nervous System Disease in Oncology Patients: A Retrospective Case Series and Literature Review","volume":"136","author":"Handley","year":"2021","journal-title":"J Clin Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nm1297-1394","article-title":"Association of Human Herpes Virus 6 (HHV-6) With Multiple Sclerosis: Increased IgM Response to HHV-6 Early Antigen and Detection of Serum HHV-6 DNA","volume":"3","author":"Soldan","year":"1997","journal-title":"Nat Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000069461.53733.f7","article-title":"The Immune Response Against Herpesvirus is More Prominent in the Early Stages of MS","volume":"60","author":"Villoslada","year":"2003","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1003138","DOI":"10.1371\/journal.ppat.1003138","article-title":"Novel Marmoset (Callithrix Jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization","volume":"9","author":"Leibovitch","year":"2013","journal-title":"PloS Pathog"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1086\/315893","article-title":"Tissue Distribution and Variant Characterization of Human Herpesvirus (HHV)-6: Increased Prevalence of HHV-6A in Patients With Multiple Sclerosis","volume":"182","author":"Akhyani","year":"2000","journal-title":"J Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.71","article-title":"Genome-Wide Association Study Does Not Reveal Major Genetic Determinants for Anti-Cytomegalovirus Antibody Response","volume":"13","author":"Kuparinen","year":"2012","journal-title":"Genes Immun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(73)90970-7","article-title":"Histocompatibility Determinants in Multiple Sclerosis, With Special Reference to Clinical Course","volume":"2","author":"Jersild","year":"1973","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211022011","article-title":"High Antibody Levels Against Human Herpesvirus-6A Interact With Lifestyle Factors in Multiple Sclerosis Development","author":"Wu","year":"2021","journal-title":"Mult Scler"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14597","article-title":"Epstein-Barr Virus Infection After Adolescence and Human Herpesvirus 6A as Risk Factors for Multiple Sclerosis","volume":"28","author":"Bistrom","year":"2021","journal-title":"Eur J Neurol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14961","article-title":"Cytomegalovirus Seropositivity Is Associated With Reduced Risk of Multiple Sclerosis-a Presymptomatic Case-Control Study","volume":"28","author":"Grut","year":"2021","journal-title":"Eur J Neurol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071059","article-title":"The Danger Model: A Renewed Sense of Self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01126.x","article-title":"Mechanisms Regulating Regional Localization of Inflammation During CNS Autoimmunity","volume":"248","author":"Pierson","year":"2012","journal-title":"Immunol Rev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10425","article-title":"Cross-Reactivity With Myelin Basic Protein and Human Herpesvirus-6 in Multiple Sclerosis","volume":"53","author":"Tejada-Simon","year":"2003","journal-title":"Ann Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e12984","DOI":"10.1111\/sji.12984","article-title":"The Role of Herpesvirus 6A and 6B in Multiple Sclerosis and Epilepsy","volume":"92","author":"Dunn","year":"2020","journal-title":"Scand J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3109\/13550289809113493","article-title":"The Effect of Human Herpesvirus-6 (HHV-6) on Cultured Human Neural Cells: Oligodendrocytes and Microglia","volume":"4","author":"Albright","year":"1998","journal-title":"J Neurovirol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(06)70006-3","article-title":"Infection of Murine Oligodendroglial Precursor Cells With Human Herpesvirus 6 (HHV-6)\u2013Establishment of a Murine In Vitro Model","author":"Mock","year":"2006","journal-title":"J Clin Virol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/13550280591002379","article-title":"Differential Tropism of Human Herpesvirus 6 (HHV-6) Variants and Induction of Latency by HHV-6A in Oligodendrocytes","volume":"11","author":"Ahlqvist","year":"2005","journal-title":"J Neurovirol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00388","article-title":"Modulatory Effects on Dendritic Cells by Human Herpesvirus 6","volume":"6","author":"Gustafsson","year":"2015","journal-title":"Front Microbiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.27.10.2204-2207.1989","article-title":"Establishment of Titration System for Human Herpesvirus 6 and Evaluation of Neutralizing Antibody Response to the Virus","volume":"27","author":"Asada","year":"1989","journal-title":"J Clin Microbiol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.20.10338-10345.2002","article-title":"Phenotypic and Functional Alterations of Dendritic Cells Induced by Human Herpesvirus 6 Infection","volume":"76","author":"Kakimoto","year":"2002","journal-title":"J Virol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.5.2807-2813.2005","article-title":"Viral Replication-Independent Blockade of Dendritic Cell Maturation and Interleukin-12 Production by Human Herpesvirus 6","volume":"79","author":"Smith","year":"2005","journal-title":"J Virol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.02.001","article-title":"Human Herpesvirus 6 Impairs Differentiation of Monocytes to Dendritic Cells","volume":"34","author":"Niiya","year":"2006","journal-title":"Exp Hematol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e58122","DOI":"10.1371\/journal.pone.0058122","article-title":"Human Herpesvirus 6A Partially Suppresses Functional Properties of DC Without Viral Replication","volume":"8","author":"Gustafsson","year":"2013","journal-title":"PloS One"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10010057","article-title":"Human Herpesvirus 6a Induces Dendritic Cell Death and HMGB1 Release Without Virus Replication","volume":"10","author":"Gustafsson","year":"2021","journal-title":"Pathogens"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(06)70005-1","article-title":"Apoptotic Effects of Human Herpesvirus-6A on Glia and Neurons as Potential Triggers for Central Nervous System Autoimmunity","author":"Gardell","year":"2006","journal-title":"J Clin Virol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.636188","article-title":"HMGB1 Activates Myeloid Dendritic Cells by Up-Regulating mTOR Pathway in Systemic Lupus Erythematosus","volume":"8","author":"Song","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116924","article-title":"High Mobility Group Box 1 (HMGB1) Protein in Multiple Sclerosis (MS): Mechanisms and Therapeutic Potential","volume":"238","author":"Paudel","year":"2019","journal-title":"Life Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1207844","article-title":"Pivotal Advance: HMGB1 Expression in Active Lesions of Human and Experimental Multiple Sclerosis","volume":"84","author":"Andersson","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-015-8673-x","article-title":"High-Mobility Group Box 1 in Multiple Sclerosis","volume":"64","author":"Sternberg","year":"2016","journal-title":"Immunol Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.67.6.789","article-title":"Human Herpesvirus 6 in Cerebrospinal Fluid of Patients Infected With HIV: Frequency and Clinical Significance","volume":"67","author":"Bossolasco","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.840753\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T01:02:14Z","timestamp":1644454934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.840753\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":86,"alternative-id":["10.3389\/fimmu.2022.840753"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.840753","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"article-number":"840753"}}